SOUTH SAN FRANCISCO, Calif., Jan. 15, 2016 (GLOBE NEWSWIRE) -- California Life Sciences Association (CLSA) today announced the appointment of Kelly Bryant as senior director, business development based in CLSA's South San Francisco office. Bryant is responsible for designing and delivering the best in class member experience that CLSA members have come to expect. Bryant will spearhead member development programs and serves as the Bay Area's trusted resource for maximizing CLSA's membership privileges. As the nation's largest statewide life sciences public policy, advocacy and business solutions organization, CLSA serves over 750 life sciences organizations across California.
Bryant will play a key role in business development and forging partnerships throughout the state, while implementing strategic programs that produce premium member value. Additionally, Bryant will serve as an ambassador for CLSA, building industry wide awareness of the CLSA member experience.
"As CLSA continues to grow and support California's life sciences economy and community, we sought an industry veteran to help meet and exceed the member goals and business objectives of our organization," said CLSA President and CEO Sara Radcliffe. "Given Kelly's extensive background and leadership qualities, CLSA members will greatly benefit from this dynamic asset."
Bryant's track record spans from the medical device, technical genomic and health sciences sectors including stints at Ceres, MDVIP (a Proctor & Gamble Co.), and Boston Scientific.
"Kelly embodies exactly what CLSA members expect when they join the most prestigious network of life sciences pioneers, risk takers and thought leaders," said Holly Smithson, Senior Vice President, Business Strategy and Development. "Kelly is a dynamic professional and committed to brokering member successes at all levels. I expect CLSA members may well enjoy her X factor."
Headshot available upon request.
About California Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the leading voice driving innovation for California's life sciences sector. We work closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California's life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state's most influential life sciences advocacy and business leadership organization. Visit CLSA at www.califesciences.org, and follow us on Twitter @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.
Contact:
Will Zasadny
Manager, Communications for CLSA
[email protected]
619-961-8848
CONTACT: Will Zasadny
Manager, Communications for CLSA
[email protected]
619-961-8848


Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report
DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States
Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process
Alibaba Stock Jumps as China Approves Apple Intelligence Powered by Qwen AI 



